scholarly journals BACKWARD WALKING AS A NEW TECHNIQUE FOR PHYSICAL REHABILITATION

Author(s):  
Aleksey Viktorovich Klemenov

Backward locomotion (backward walking and running) is increasingly used in sports and medicine. Kinetic and kinematic analysis of backward walking showed its advantages over the usual method of movement that can be successfully used in the athletic training and for treatment and rehabilitation after various diseases. During sports training backward walking/running can be used as one of the methods of fitness to improve physical endurance. Backward walking leads to a more cardiovascular and respiratory load and a more significant aerobic and anaerobic capacity of the organism compared with forward walking at similar parameters of physical activity. Backward walking is associated with less overload on knee joints, it is also one of the few natural ways of strengthening the quadriceps. Backward walking is used to elaborate the correct pattern of gait in children with cerebral palsy, in persons with hemiplegia after stroke, in patients suffering from Parkinson’s disease and multiple sclerosis, in spinal cord injured patients. Regular backward walking trainings improve spatial-temporal parameters of walking and balance, increase muscle strength of the lower limbs in these diseases. There is an information about the application of backward walking exercises in diabetic foot syndrome in order to reduce a plantar pressure and in physical rehabilitation of postoperative patients. Tests with backward walking are used for diagnostic purposes - to assess the severity of impaired coordination and motor skills in post-stroke patients and in Parkinson’s disease, to identify the minimal walking impairment in persons with multiple sclerosis and for probability of falling prediction in elderly individuals and patients with dizziness.

Author(s):  
Grace K. Kellaher ◽  
Sidney T. Baudendistel ◽  
Ryan T. Roemmich ◽  
Matthew J. Terza ◽  
Chris J. Hass

2021 ◽  
Vol 27 ◽  
Author(s):  
Niklas Frahm ◽  
Michael Hecker ◽  
Uwe Zettl

: Polypharmacy is an important aspect of medication management and particularly affects elderly and chronically ill people. Patients with dementia, Parkinson’s disease (PD) or multiple sclerosis (MS) are at high risk for multimedication due to their complex symptomatology. Our aim was to provide an overview of different definitions of polypharmacy and to present the current state of research on polypharmacy in patients with dementia, PD or MS. The most common definition of polypharmacy in the literature is the concomitant use of ≥5 medications (quantitative definition approach). Polypharmacy rates of up to >50% have been reported for patients with dementia, PD or MS, although MS patients are on average significantly younger than those with dementia or PD. The main predictor of polypharmacy is the complex symptom profile of these neurological disorders. Potentially inappropriate medication (PIM), drug-drug interactions, poor treatment adherence, severe disease course, cognitive impairment, hospitalisation, poor quality of life, frailty and mortality have been associated with polypharmacy in patients with dementia, PD or MS. For patients with polypharmacy, either the avoidance of PIM (selective deprescribing) or the substitution of PIM with more suitable drugs (appropriate polypharmacy) is recommended to achieve a more effective therapeutic management.


Author(s):  
G. Belgiovine ◽  
M. Capecci ◽  
L. Ciabattoni ◽  
M. C. Fiorentino ◽  
G. Foresi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document